Patent · US Active

Compositions and methods for treating or preventing prostate cancer and for detecting androgen receptor variants

US12084723B2 · kind B2 · utility

0Cited by
26References
17Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 10, 2020
Grant dateSep 10, 2024
Priority date
Expiry dateOct 8, 2042

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/56
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention features diagnostic and therapeutic methods and compositions featuring androgen receptor variant proteins and nucleic acid molecules whose expression is increased in androgen related diseases or disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.